Use of THRIVE for Apneic Oxygenation in Transoral Laser Microlaryngeal Surgery: A Scoping Review
The Laryngoscope · 2024
DOI: 10.1002/lary.31483 ↗Kurz gefasst
Scoping Review in der Zeitschrift The Laryngoscope, 2024. Verfasst von Saikrishna Ananthapadmanabhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Westmead Hospital, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Laser Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Objectives
Trans‐nasal humidified rapid insufflation ventilatory exchange (THRIVE) has demonstrated utility in extending the apneic window in the perioperative setting. Its benefits in facilitating tubeless anesthesia are recognized during elective laryngotracheal surgeries. The use of THRIVE and administering higher fractional inspired oxygen concentrations in laser laryngeal surgery (LLS) remains controversial due to the theoretical risk of airway fires. A scoping review of the literature describing institutional experiences with THRIVE during LLS was conducted. Data Sources and Review Methods A systematic scoping review of the literature was performed including PubMed, Medline, Embase, Scopus, JBI EBP Database, and Cochrane Library from inception to April 2023.
Results
From the 472 articles identified in our review, nine articles were included representing 271 cases. THRIVE was used for preoxygenation and to maintain apneic oxygenation during LLS. Different institutional practices related to THRIVE parameters and intraoperative modifications during lasing were described in the literature, including cessation of THRIVE, reduction of FiO 2 to 30%, and continuous 100% FiO 2 oxygenation. One study described a brief ignition of the coating of a KTP laser fiber without injury to the patient. No adverse patient outcomes have been documented in the literature with THRIVE during LLS.
Conclusion
THRIVE is a safe and effective form of tubeless anesthesia and apneic oxygenation during LLS, with no adverse patient safety events reported in the literature. Key determinants to maintain safety include optimal patient and team selection, effective surgeon‐anesthetist cooperation, and institutional protocols that govern intraoperative practice. Laryngoscope , 134:4203–4212, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Westmead Hospital, Westmead, New South Wales, Australia.
- Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia.
- Department of Head and Neck Surgical Oncology, Cytecare Cancer Hospital, Bangalore, Karnataka, India.
- Department of Anaesthesia, Critical Care, and Pain, Cytecare Cancer Hospital, Bangalore, Karnataka, India.
- Department of Otolaryngology, Macquarie University, Macquarie Park, New South Wales, Australia.
- The Canterbury Hospital, Campsie, New South Wales, Australia.
ORCID-Profile: Saikrishna Ananthapadmanabhan
Zitieren
APA
Ananthapadmanabhan, S., Gan, Y. J., Kudpaje, A., Raju, D., Smith, M., Riffat, F., Novakovic, D., Stokan, M., & Palme, C. E. (2024). Use of THRIVE for Apneic Oxygenation in Transoral Laser Microlaryngeal Surgery: A Scoping Review. The Laryngoscope. https://doi.org/10.1002/lary.31483
Vancouver
Ananthapadmanabhan S, Gan YJ, Kudpaje A, Raju D, Smith M, Riffat F, et al. Use of THRIVE for Apneic Oxygenation in Transoral Laser Microlaryngeal Surgery: A Scoping Review. The Laryngoscope. 2024. doi:10.1002/lary.31483
BibTeX
@article{Ananthapadmanabhan2024,
author = {Ananthapadmanabhan, Saikrishna and Gan, Yijin J and Kudpaje, Akshay and Raju, Dinesh and Smith, Mark and Riffat, Faruque and Novakovic, Daniel and Stokan, Murray and Palme, Carsten E},
title = {Use of THRIVE for Apneic Oxygenation in Transoral Laser Microlaryngeal Surgery: A Scoping Review},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31483}
}
EUVIMED